|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||||||||||||||||||||||||
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||||||||||||||||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||||||||||||||||||||||||||||
|
|
Improved Detection Increases Biopsy Needs Radiologists at the IBC have seen a moderate increase in the need to provide core biopsies over the past few years. Part of this increase has occurred with improved detection using mammography and ultrasound, but the use of breast MRI has also brought about greater sensitivity in the detection of lesions. Breast MRI is becoming a regular step of evaluation for extent of disease and surgical planning for newly diagnosed cancer patients and for the evaluation of high-risk patients with dense tissue.
Mobile System Offers Multiple Solutions It is very common for patients to present with more than one suspicious lesion and it is equally as common for more than one imaging modality to be required for the core biopsies. Dr. Spears said it is a necessity to have core biopsy equipment and tissue markers that can be used with all three imaging modalities. "The Suros system easily gives us this capability. It is very mobile, easy to set up, easy to use for radiologists and technologists, accurate, and comfortable for the patient. We can't afford to have a separate piece of equipment for each imaging modality and we don't have the space." Percutaneous core biopsy methods of obtaining tissue for histologic diagnosis has become an integral tool of breast imaging centers, saving the patient and health care system time and money. The core biopsy can be performed in an office setting and may prevent a patient from undergoing a more invasive and more expensive open surgical procedure if the diagnosis is benign. A malignant diagnosis by core biopsy can provide useful information in surgical planning, possibly requiring the patient to undergo only one surgical procedure rather than two.
New and improving imaging systems are likely to force an increased need for diagnostic core biopsy with its highly sensitive technology that allows for the detection and diagnosis of more lesions and cancers of the breast than ever before. Radiologists not only have to be skilled in the evaluation of images from each modality, but they also have to determine the best biopsy approach(es) to provide accurate tissue diagnosis after finding an area of suspicion and be able to procure that tissue by percutaneous biopsy with each of those imaging modalities when indicated. The biopsy system also needs to be adaptable to these imaging advances. Dr. Spears notes that the ATECŪ system is able to handle the expected increase in biopsy volume and they purchased the system believing it will be easily compatible with emerging imaging modalities. "Versatility is the key to staying current with technology and to continuing the best and most compassionate patient care possible," Dr. Spears said. "You have to make good business decisions while remaining true to your patients and your mission. And that means providing the best technology with optimal cost efficient results." |
||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||
| Home | Women's Health | R2 CAD | Suros Surgical | Skeletal Health | OEM Solutions | Customer Care Center | |||||||||||||||||||||||||||||||||||
| Learning
Center | News & Events | Investor
Relations | About Hologic More Information | Locate Us | Terms of Use | Privacy Policy Copyright 2007 Hologic, Inc. All Rights Reserved. |
|||||||||||||||||||||||||||||||||||